Pharmstandard to Buy Ingredient Supplier for $590 Million

15.08.2013 - Russian drugmaker Pharmstandard has agreed to buy a supplier of ingredients for its flagship anti-viral and anxiety drugs for $590 million, as part of a plan to spin off its over...